← Home
/
ULTRAGENYX PHARMACEUTICAL INC. (RARE)
Stock Analysis
ULTRAGENYX PHARMACEUTICAL INC. (RARE)
RARE
RARE · Market data
26.91
+8.29%
Updated: 2026-06-18 13:40 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 27.05. Holding above 26.83 keeps the current thesis intact.
✓
Fundamentals
Weak / Negative
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
26.83
↗
Break Above
Confirmation improves above resistance.
27.05
🎯
Next Objective
Pattern-derived target if setup continues.
31.03
×
Thesis Break
Scenario weakens below invalidation.
Below 26.83
What's Driving RARE?
📈 Technical recovery is improving
Momentum is Neutral. Watch 27.05 for confirmation and 26.83 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 26.85 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Breakout
Downtrend Break · 2 bars old · score 100
◎
How to read this setup
Fresh structural signal: downtrend break age is 2 bars, so the breakout is still relatively recent.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
📈 Net Income
-185.00M
↘ Negative
🧮 EPS (Basic)
-1.84
↘ Negative
ULTRAGENYX PHARMACEUTICAL INC.
Note: This is an algorithmic technical snapshot, not financial advice.